Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yupeng Feng, Chufang Li, Peiyu Hu, Qian Wang, Xuehua Zheng, Yongkun Zhao, Yi Shi, Songtao Yang, Changhua Yi, Ying Feng, Chunxiu Wu, Linbing Qu, Wei Xu, Yao Li, Caijun Sun, Fu Geroge Gao, Xianzhu Xia, Liqiang Feng & Ling Chen. (2018) An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques. Emerging Microbes & Infections 7:1, pages 1-12.
Read now
Read now
Sara Viksmoen Watle, Gunnstein Norheim & John-Arne Røttingen. (2016) Ebola vaccines – Where are we?. Human Vaccines & Immunotherapeutics 12:10, pages 2700-2703.
Read now
Read now
Articles from other publishers (13)
Duncan G. Ithinji, David W. Buchholz, Shahrzad Ezzatpour, I. Abrrey Monreal, Yu Cong, Julie Sahler, Amandip Singh Bangar, Brian Imbiakha, Viraj Upadhye, Janie Liang, Andrew Ma, Birgit Bradel-Tretheway, Benjamin Kaza, Yao Yu Yeo, Eun Jin Choi, Gunner P. Johnston, Louis Huzella, Erin Kollins, Saurabh Dixit, Shuiqing Yu, Elena Postnikova, Victoria Ortega, Avery August, Michael R. Holbrook & Hector C. Aguilar. (2022) Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses. npj Vaccines 7:1.
Crossref
Crossref
Selina Khan, Nadine C. Salisch, Ana Izquierdo Gil, Satish Boedhoe, Karin Feddes-de Boer, Jan Serroyen, Hanneke Schuitemaker & Roland C. Zahn. (2022) Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets. npj Vaccines 7:1.
Crossref
Crossref
Maria G. Byazrova, Ekaterina A. Astakhova, Aygul R. Minnegalieva, Maria M. Sukhova, Artem A. Mikhailov, Alexey G. Prilipov, Andrey A. Gorchakov & Alexander V. Filatov. (2022) Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination. npj Vaccines 7:1.
Crossref
Crossref
Coralie F. Daussy, Noémie Pied & Harald Wodrich. (2021) Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties. Viruses 13:7, pages 1221.
Crossref
Crossref
Susanne Modrow, Uwe Truyen & Hermann SchätzlSusanne Modrow, Uwe Truyen & Hermann Schätzl. 2021. Molekulare Virologie. Molekulare Virologie
121
130
.
Matthew Charman, Christin Herrmann & Matthew D. Weitzman. (2019) Viral and cellular interactions during adenovirus DNA replication. FEBS Letters 593:24, pages 3531-3550.
Crossref
Crossref
Pedro M. Folegatti, Duncan Bellamy, Rachel Roberts, Jonathan Powlson, Nick J. Edwards, Catherine F. Mair, Georgina Bowyer, Ian Poulton, Celia H. Mitton, Nicky Green, Eleanor Berrie, Alison M. Lawrie, Adrian V.S. Hill, Katie J. Ewer, John Hermon-Taylor & Sarah C. Gilbert. (2019) Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine. Vaccines 7:2, pages 40.
Crossref
Crossref
Aurélie Ploquin, Kendra Leigh & Nancy J. Sullivan. 2018. Plotkin's Vaccines. Plotkin's Vaccines
276
287.e5
.
Rika Gomi, Anurag Sharma, Wenzhu Wu, Biin Sung & Stefan Worgall. (2017) Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection. Vaccine 35:51, pages 7174-7180.
Crossref
Crossref
Anita Milicic, Christine S. Rollier, Choon Kit Tang, Rhea Longley, Adrian V. S. Hill & Arturo Reyes-Sandoval. (2017) Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria. Scientific Reports 7:1.
Crossref
Crossref
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenMike Bray & Daniel S. Chertow. 2016. Clinical Virology. Clinical Virology
981
1007
.
Carmen W.E. Embregts & Maria Forlenza. (2016) Oral vaccination of fish: Lessons from humans and veterinary species. Developmental & Comparative Immunology 64, pages 118-137.
Crossref
Crossref
Julio Alonso-Padilla, Tibor Papp, Győző L Kaján, Mária Benkő, Menzo Havenga, Angelique Lemckert, Balázs Harrach & Andrew H Baker. (2016) Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs. Molecular Therapy 24:1, pages 6-16.
Crossref
Crossref